BioCardia (BCDA) Cash & Equivalents Growth (1y) (2011 - 2026)
Powered by 
Analysis
BioCardia (BCDA) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.36 Bn | 112.79 Mn | 20.89% |
| 2 | CRISPR Therapeutics AG | 5.05 Bn | 5.05 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.74 Bn | 3.45 Bn | 55.72 Mn | -16.36% |
| 4 | Legend Biotech | 3.57 Bn | 2.61 Bn | 251.50 Mn | -30.46% |
| 5 | uniQure | 3.00 Bn | 3.00 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | - |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.21 Bn | 1.42 Bn | 251.87 Mn | 13.01% |
| 9 | Vericel | 1.95 Bn | 1.79 Bn | 56.40 Mn | 55.71% |
| 10 | BioCardia | 13.18 Mn | 9.06 Mn | - | 320.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 320.10% |
| Mar 31, 2026 | 0.21% |
| Dec 31, 2025 | 5.27% |
| Sep 30, 2025 | 7.51% |
| Jun 30, 2025 | -31.03% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 114.96% |
| Sep 30, 2024 | 168.66% |
| Jun 30, 2024 | -66.99% |
| Mar 31, 2024 | -80.46% |
| Dec 31, 2023 | -85.02% |
| Sep 30, 2023 | -72.48% |
| Jun 30, 2023 | -50.02% |
| Mar 31, 2023 | -27.51% |
| Dec 31, 2022 | -42.80% |
| Sep 30, 2022 | -58.07% |
| Jun 30, 2022 | -53.55% |
| Mar 31, 2022 | -68.84% |
| Dec 31, 2021 | -39.87% |
| Sep 30, 2021 | 115.10% |